TABLE 2.
Characteristic | Estimate | 95% CI | P |
---|---|---|---|
Age | 0.040 | 0.02, 0.05 | <0.0001* |
Smoking | −0.200 | −0.39, −0.03 | 0.0218* |
Sex | 0.150 | 0.03, 0.26 | 0.0112* |
Race | 0.1134 | ||
White | 0.056 | −0.17, 0.32 | |
Black | 0.273 | 0.01, 0.556 | |
Histology | 0.1735 | ||
Adenocarcinoma | −0.051 | −0.26, 0.15 | |
NSCLC | 0.072 | −0.11, 0.26 | |
SCC | 0.203 | −0.01, 0.41 | |
Stage | −0.070 | −0.19, 0.05 | 0.263 |
Treatment | 0.0154* | ||
Surgery | −0.100 | −0.2, 0.05 | |
Radiation | 0.250 | 0.08, 0.42 | |
Time to scan | −0.001 | −0.01, 0.002 | 0.4647 |
Clinical suspicion | −0.060 | −0.18, 0.05 | 0.2669 |
PET result | −0.290 | −0.41, −0.18 | <0.0001* |
Significant variables.
NSCLC = non–small cell lung cancer; SCC = squamous cell carcinoma.